☰

Yven Van Herrewege, Ph.D. - Publications

Affiliations: 
2004 Universiteit Antwerpen (Belgium) 
Area:
Medicine and Surgery, Public Health
Tree Info Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Van Dijck C, Tsoumanis A, Rotsaert A, Vuylsteke B, Van den Bossche D, Paeleman E, De Baetselier I, Brosius I, Laumen J, Buyze J, Wouters K, Lynen L, Van Esbroeck M, Herssens N, Abdellati S, ... ... Van Herrewege Y, et al. Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial. The Lancet. Infectious Diseases. PMID 33676596 DOI: 10.1016/S1473-3099(20)30778-7  0.355
2009 Jenabian MA, Saïdi H, Charpentier C, Van Herrewege Y, Son JC, Schols D, Balzarini J, Vanham G, Bélec L. In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20). The Journal of Antimicrobial Chemotherapy. 64: 1192-5. PMID 19875507 DOI: 10.1093/jac/dkp380  0.676
2008 Terrazas-Aranda K, Van Herrewege Y, Hazuda D, Lewi P, Costi R, Di Santo R, Cara A, Vanham G. Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection. Antimicrobial Agents and Chemotherapy. 52: 2544-54. PMID 18474579 DOI: 10.1128/Aac.01627-07  0.704
2008 Vermeire K, Brouwers J, Van Herrewege Y, Le Grand R, Vanham G, Augustijns P, Bell TW, Schols D. CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor. Current Hiv Research. 6: 246-56. PMID 18473788 DOI: 10.1016/J.Antiviral.2009.02.161  0.736
2008 Van Herrewege Y, Morellato L, Descours A, Aerts L, Michiels J, Heyndrickx L, Martin L, Vanham G. CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides. The Journal of Antimicrobial Chemotherapy. 61: 818-26. PMID 18270220 DOI: 10.1093/jac/dkn042  0.675
2008 Heyndrickx L, Vermoesen T, Vereecken K, Kurth J, Coppens S, Aerts L, Ohagen A, Van Herrewege Y, Lewi P, Vanham G. Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays. Journal of Virological Methods. 148: 166-73. PMID 18192031 DOI: 10.1016/j.jviromet.2007.11.009  0.647
2007 Terrazas-Aranda K, Van Herrewege Y, Lewi PJ, Van Roey J, Vanham G. In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection. Antiviral Chemistry & Chemotherapy. 18: 141-51. PMID 17626598 DOI: 10.1177/095632020701800304  0.711
2007 Jespers V, Laga M, Van Herrewege Y, Vanham G. Microbicides a long and bumpy road to success? Aids Reviews. 9: 61-2. PMID 17474314  0.394
2007 Van Herrewege Y, Michiels J, Waeytens A, De Boeck G, Salden E, Heyndrickx L, van den Mooter G, de Béthune MP, Andries K, Lewi P, Praet M, Vanham G. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides. Antiviral Research. 74: 111-24. PMID 17097156 DOI: 10.1016/j.antiviral.2006.10.010  0.753
2007 Balzarini J, Van Herrewege Y, Vermeire K, Vanham G, Schols D. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes. Molecular Pharmacology. 71: 3-11. PMID 17056872 DOI: 10.1124/mol.106.030155  0.699
2004 Van Herrewege Y, Vanham G, Michiels J, Fransen K, Kestens L, Andries K, Janssen P, Lewi P. A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides. Antimicrobial Agents and Chemotherapy. 48: 3684-9. PMID 15388420 DOI: 10.1128/Aac.48.10.3684-3689.2004  0.699
2004 Van Herrewege Y, Michiels J, Van Roey J, Fransen K, Kestens L, Balzarini J, Lewi P, Vanham G, Janssen P. In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides. Antimicrobial Agents and Chemotherapy. 48: 337-9. PMID 14693562 DOI: 10.1128/Aac.48.1.337-339.2004  0.707
2002 Balzarini J, Van Herrewege Y, Vanham G. Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cells. Aids (London, England). 16: 2159-63. PMID 12409737  0.697
2002 Van Herrewege Y, Penne L, Vereecken C, Fransen K, van der Groen G, Kestens L, Balzarini J, Vanham G. Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission. Aids Research and Human Retroviruses. 18: 1091-102. PMID 12396448 DOI: 10.1089/088922202320567833  0.689
Show low-probability matches.